- Home
- ISRG vs MRK Comparison
ISRG vs MRK Comparison
Compare ISRG & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRG
- MRK
- Stock Information
- Founded
- ISRG 1995
- MRK 2000
- Country
- ISRG United States
- MRK United States
- Employees
- ISRG N/A
- MRK N/A
- Industry
- ISRG Medical/Dental Instruments
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- ISRG Health Care
- MRK Health Care
- Exchange
- ISRG Nasdaq
- MRK Nasdaq
- Market Cap
- ISRG 202.8B
- MRK 218.2B
- IPO Year
- ISRG 2000
- MRK N/A
- Fundamental
- Price
- ISRG $552.34
- MRK $76.82
- Analyst Decision
- ISRG Strong Buy
- MRK Buy
- Analyst Count
- ISRG 18
- MRK 15
- Target Price
- ISRG $587.00
- MRK $113.71
- AVG Volume (30 Days)
- ISRG 1.4M
- MRK 14.7M
- Earning Date
- ISRG 07-17-2025
- MRK 04-24-2025
- Dividend Yield
- ISRG N/A
- MRK 4.22%
- EPS Growth
- ISRG 23.31
- MRK 667.14
- EPS
- ISRG 6.83
- MRK 6.88
- Revenue
- ISRG $8,714,900,000.00
- MRK $63,922,000,000.00
- Revenue This Year
- ISRG $17.90
- MRK $2.42
- Revenue Next Year
- ISRG $15.15
- MRK $5.64
- P/E Ratio
- ISRG $80.86
- MRK $11.17
- Revenue Growth
- ISRG 19.08
- MRK 4.10
- 52 Week Low
- ISRG $396.48
- MRK $73.31
- 52 Week High
- ISRG $616.00
- MRK $134.63
- Technical
- Relative Strength Index (RSI)
- ISRG 58.10
- MRK 44.17
- Support Level
- ISRG $529.15
- MRK $75.59
- Resistance Level
- ISRG $559.80
- MRK $78.20
- Average True Range (ATR)
- ISRG 9.12
- MRK 2.03
- MACD
- ISRG -1.66
- MRK 0.21
- Stochastic Oscillator
- ISRG 58.65
- MRK 44.10
About ISRG Intuitive Surgical Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.